Methadone Clinics in Massachusetts

Methadone clinics in Massachusetts specialize in providing effective treatment for opiate addictions including addiction to heroin, Vicodin, Oxycontin or Oxycodone.

Methadone Clinics in cities of Massachusetts

Opioid Use Disorder Treatment Across Massachusetts: What is Available and Where

Massachusetts has one of the more built-out treatment systems in the country for opioid use disorder (OUD), with opioid treatment programs concentrated in Boston, Worcester, Springfield and the larger Gateway Cities. Office-based prescribers and telehealth fill in much of the rest of the state, including the Cape, the Islands and the western counties.

The three FDA-approved medications for opioid use disorder, methadone, buprenorphine and naltrexone, are all available here, in both clinic and office-based settings. The clinic listings on this page are your starting point. If you are not sure where to begin, the helpline can talk through your options with you.

Your Medication and Setting Options in Massachusetts

There are three medications approved to treat opioid use disorder. Understanding them is the clearest way to read the listings on this page.

Methadone for OUD is provided only through a licensed opioid treatment program, often called an OTP or methadone clinic, not a regular pharmacy. You go to the program to be dosed, with take-home doses added over time as treatment stabilizes.

Buprenorphine, which includes Suboxone and other buprenorphine-naloxone products, along with the extended-release monthly injection Sublocade, works differently. Any clinician with a standard DEA registration can prescribe it in an office, and you fill it at a pharmacy. Many OTPs offer it too.

Naltrexone, including the monthly Vivitrol injection, is not a controlled substance and any licensed provider can prescribe it. Before starting, you have to be off opioids for a set period to avoid a hard withdrawal reaction. A clinician will work with you to determine when it is safe to start.

Those two settings, the opioid treatment program (OTP) and office-based opioid treatment (OBOT) in a doctor’s office or health center, are what the listings represent. If you want to understand the trade-offs before you call, it helps to read how methadone and Suboxone compare day to day and to look at what to expect from an OTP.

Choosing among medications is a decision you make with a clinician. Each one is effective, but the right fit depends on your history and your life.

State Rules, MassHealth Coverage and How Massachusetts Applies the Federal Flexibilities

MassHealth, the state’s Medicaid program, covers all three medications for opioid use disorder, including methadone dosing at OTPs, buprenorphine products filled at a pharmacy and the Vivitrol injection, under both fee-for-service and managed care plans.

Federal law has required every state Medicaid program to cover methadone since 2020, and the 2024 Consolidated Appropriations Act made that requirement permanent. On top of insurance, the state Bureau of Substance Addiction Services (BSAS) acts as the payer of last resort, funding treatment for people who are uninsured or underinsured.

Massachusetts also leans into the federal access changes of recent years. Since 2023, any provider with a standard DEA registration can prescribe buprenorphine, which widened where you can get it.

SAMHSA’s 2024 update to the federal OTP rules (42 CFR Part 8) expanded take-home methadone to as much as a 28-day supply for patients who are stable in treatment, allowed treatment to start by telehealth and removed older admission barriers. Take-home eligibility is decided by your program based on stability.

As of June 2026, buprenorphine can also be started through telehealth, including by phone in many cases, without a prior in-person visit. Those telehealth rules run through the end of 2026 and are still being finalized, so confirm current options with a provider.

Methadone for OUD remains dispensed through an OTP. Staying on a steady, effective dose matters more than the calendar; here is why your methadone dose is worth protecting if you transfer or travel.

The Overdose Picture in Massachusetts, and Why Treatment is the Response

The trend in Massachusetts has turned sharply in the right direction. The Massachusetts Department of Public Health reported 978 confirmed and estimated opioid-related overdose deaths statewide in 2025. This was the first time the count has fallen below 1,000 since 2013, after a roughly 36 percent drop in 2024 and a 10 percent decline in 2023.

State officials credit sustained investment in treatment, naloxone and harm reduction, along with shifts in the drug supply. However, the supply itself remains dangerous. Fentanyl was present in around 90 percent of fatal opioid overdoses where toxicology was available, and the sedative xylazine, which naloxone does not reverse, is showing up more often.

The takeaway is not that the danger has passed but that getting onto medication works, and the options to do so are on this page.

How to Find Treatment and Take the First Step

Starting treatment usually begins with an intake assessment, where a clinician reviews your history and helps you choose a medication. Some Massachusetts programs offer same-day or next-day starts, and many emergency departments can begin buprenorphine and connect you to ongoing care.

One thing worth planning with a clinician is the timing of your first dose because starting buprenorphine too soon after using fentanyl can trigger sudden, severe withdrawal, called precipitated withdrawal.

To understand the medical side of getting started, you can read more about methadone treatment when fentanyl is involved and about opioid use disorder treatment generally.

Use the clinic listings above to find a provider near you, or call the helpline to talk through where to start.

Special Situations: Pregnancy, Reentry and People Leaving Incarceration

For people who are pregnant, continuing or starting medication for opioid use disorder is the recommended standard of care. Methadone and buprenorphine are both used during pregnancy, and stopping suddenly carries real risk. Treatment is a positive health decision, and Massachusetts providers experienced in perinatal care can walk you through it.

You can read more about methadone and pregnancy and about how families can help.

Massachusetts is also one of the few states where every state, county and federal correctional facility maintains all three forms of MOUD. The U.S. Attorney’s Office confirmed statewide coverage in 2022, and Franklin County was the first jail in the country to offer all three.

That matters for continuity, because the highest-risk moment for a return to use and overdose is the period right after release and staying on medication through a jail stay and into reentry sharply lowers that risk.

For involuntary commitment questions under the state’s Section 35 law or court-ordered care, ask any program on this page how they handle referrals.

Naloxone and Overdose Safety in Massachusetts

Naloxone, the medication that reverses an opioid overdose, is widely available in Massachusetts. Under a statewide standing order (M.G.L. c. 94C, § 19B), any pharmacy can dispense it without an individual prescription, and over-the-counter Narcan is also on the shelf.

The state’s Community Naloxone Purchasing Program distributes free kits through community organizations, and Massachusetts law protects anyone who, acting in good faith, administers naloxone during an overdose.

Another important harm reduction resource is the DPH-funded SafeSpot overdose prevention helpline (1-800-972-0590), where a representative can stay on the line with someone who is using.

Carrying naloxone is a practical step for anyone in treatment or anyone close to a person who uses opioids. Keep in mind that a return to use is a common, manageable part of recovery, not a failure, and naloxone keeps that moment survivable.

You can read more about overdose risk and how to respond.

Common Questions About Treatment in Massachusetts

Does MassHealth cover methadone and Suboxone?

Yes. MassHealth covers all three medications for opioid use disorder, including methadone dosing at an OTP, buprenorphine and Suboxone filled at a pharmacy and the Vivitrol injection, under both fee-for-service and managed care plans. Uninsured people may qualify for state-funded treatment through the Bureau of Substance Addiction Services.

What is the difference between a methadone clinic and a Suboxone doctor?

A methadone clinic, or OTP, dispenses methadone on site, with take-home doses earned over time. An OTP can also offer buprenorphine and naltrexone.

A Suboxone prescriber works in an office or health center, writes a prescription you fill at a pharmacy, and usually sees you less often once you are stable. Both are legitimate; the choice depends on the medication and structure that fit you. See how the two compare.

Can I start Suboxone by telehealth in Massachusetts?

As of June 2026, yes, buprenorphine can be started by telehealth, including by phone in many cases, without a prior in-person visit. These flexibilities are in effect through the end of 2026. As the rules are still being finalized, be sure to confirm current options with the provider you choose.

Do I have to go to the clinic every day for methadone?

At first, often yes, but not forever. Federal rules updated in 2024 expanded take-home methadone to as much as a 28-day supply for patients who are stable in treatment, on a graduated schedule. Your program decides take-home eligibility based on how treatment is going. Learn more about how methadone works as a long-term medication.

Is medication just trading one drug for another?

No. This is a common myth. Methadone and buprenorphine are prescribed in steady doses that prevent withdrawal and cravings without the cycle of illicit use. In fact, decades of evidence show they cut the risk of overdose death roughly in half.

Long-term medication is legitimate, effective care, the way ongoing medication is for other chronic conditions.

About This Page

Last reviewed July 2026.

Sources:

Massachusetts Department of Public Health, opioid-related overdose death data, 2024 and 2025.
MassHealth and the Massachusetts Bureau of Substance Addiction Services, MOUD coverage.
SAMHSA and DEA, federal regulations on buprenorphine prescribing, OTP take-home and telehealth rules (42 CFR Part 8, 2024), and buprenorphine telemedicine, 2025 to 2026.
U.S. Attorney’s Office, District of Massachusetts, correctional MOUD review, 2022.
Massachusetts General Laws c. 94C, § 19B, naloxone standing order.

MethadoneCenters.com is a referrer service that provides information about addiction treatment practitioners and facilities. It is not a medical provider or treatment facility and does not provide medical advice. The information here is not a substitute for professional treatment advice; decisions about medication and treatment should be made with a qualified clinician.

Calls to any general helpline on this site may be answered by a paid advertiser. We do not receive a commission or fee dependent on which treatment provider a caller chooses, and there is no obligation to enter treatment. To reach non-sponsor options, you can browse the directory listings or visit SAMHSA at samhsa.gov/find-help.